Rendimiento de los indicadores tras la implementación del Documento de consenso español para el control de la hiperglucemia en el hospital y al alta / Indicator performance after the implementation of the Spanish Consensus Document for the control of hyperglycemia in the hospital and at discharge

Antecedentes y objetivos: la información sobre el manejo de los pacientes diabéticos en el momento del alta hospitalaria es reducida. El objetivo del estudio fue evaluar el impacto de la implementación de las recomendaciones del Consenso español para el manejo del alta hospitalaria en pacientes con diabetes tipo 2 (DM2) o hiperglucemia durante la hospitalización. Métodos: estudio observacional con un grupo de recogida prospectiva y otra retrospectiva de pacientes con DM2/hiperglucemia (> 140mg/dl) durante la hospitalización de 19 hospitales españoles. Se recopilaron indicadores de calidad en el informe de alta, terapia hipoglucémica, HbA1c y eventos adversos al ingreso, en el momento del alta y a los 3 meses del alta. Resultados: se incluyó a 199 pacientes en el grupo prospectivo y 75 en el retrospectivo. Los indicadores de calidad del informe de alta hospitalaria fueron mayores en el grupo prospectivo (p<0,001). La proporción de pacientes con tratamiento de insulina, fármacos antidiabéticos orales (ADO) e insulina+ADO sufrió modificaciones en el momento del alta hospitalaria de los pacientes del grupo prospectivo con HbA1c<7,5% (p<0,005) y ≥ 7,5% (p<0,001), y en los pacientes del grupo retrospectivo con HbA1c ≥ 7,5% (p<0,001). En el mes 3 tras el alta, los niveles de HbA1c descendieron de 8,2± 1,9% a 7,3±1,2% (p<0,001) en el grupo prospectivo y desde 8,2±1,9% a 7,3±1,2% (p<0,001) en el retrospectivo. Los episodios de hipoglucemia e hiperglucemia así como los de reingreso fueron semejantes en ambos grupos. Conclusiones: la aplicación del documento español de consenso de las recomendaciones para el manejo del alta hospitalaria en pacientes con DM2 o hiperglucemia mejora de forma considerable el registro de indicadores de calidad en el informe de alta. La conciliación de la medicación antidiabética en el momento del alta hospitalaria mejora el control glucémico después del alta

Background and aims: information for the adequate management of diabetic patients at hospital discharge is limited. We aimed to evaluate the impact of implementation of recommendations of the Spanish consensus for the management hospital discharge in patients with type 2 diabetes or hyperglycaemia during hospitalization. Methods: observational multicentric study with a prospective and a retrospective colection of patients with type 2 diabetes /hyperglycaemia (>140mg/dl) during hospitalization from 19 Spanish hospitals. Quality indicators in discharge report, antidiabetic therapy, HbA1c and adverse events were gathered at hospital admission, hospital discharge and 3 month post-discharge. Results: 199 and 75 subjects in the prospective and retrospective group respectively were included. The indicators of quality in the hospital discharge reports was higher in the prospective group (P<.001). The proportion of patients with insulin, oral antidiabetic drugs (OADs), and insulin+OADs was modified at discharge in patients with HbA1c<7.5% (P<.005) and ≥7.5% (P<.001) in the prospective group and in patients with HbA 1c ≥7.5% (P<.001) in the retrospective group. At 3 month post-discharge HbA1c levels decreased from 8.2±1.9% to 7.3±1.2% (P<.001) in the prospective group, and from 8.3±1.5% to 7.2±1.2% (P<.001) in the retrospective group. Hypoglycaemic and hyperglycaemic episodes and hospital readmissions were similar in both groups. Conclusions: implementation of Spanish consensus recommendations for the management of hospital discharge in patients with diabetes type 2 or hyperglycaemia considerably improved the registration of quality indicators in the discharge report. Reconciliation of antidiabetic medication at the time of hospital discharge, improves glycaemic control after hospital discharge

Indicator performance after the implementation of the Spanish Consensus Document for the control of hyperglycemia in the hospital and at discharge. / Rendimiento de los indicadores tras la implementación del Documento de consenso español para el control de la hiperglucemia en el hospital y al alta.

BACKGROUND AND AIMS: Information for the adequate management of diabetic patients at hospital discharge is limited. We aimed to evaluate the impact of implementation of recommendations of the Spanish consensus for the management hospital discharge in patients with type 2 diabetes or hyperglycaemia during hospitalization. METHODS: Observational multicentric study with a prospective and a retrospective colection of patients with type 2 diabetes /hyperglycaemia (>140mg/dl) during hospitalization from 19 Spanish hospitals. Quality indicators in discharge report, antidiabetic therapy, HbA1c and adverse events were gathered at hospital admission, hospital discharge and 3 month post-discharge. RESULTS: 199 and 75 subjects in the prospective and retrospective group respectively were included. The indicators of quality in the hospital discharge reports was higher in the prospective group (P<.001). The proportion of patients with insulin, oral antidiabetic drugs (OADs), and insulin+OADs was modified at discharge in patients with HbA1c<7.5% (P<.005) and ≥7.5% (P<.001) in the prospective group and in patients with HbA 1c ≥7.5% (P<.001) in the retrospective group. At 3 month post-discharge HbA1c levels decreased from 8.2±1.9% to 7.3±1.2% (P<.001) in the prospective group, and from 8.3±1.5% to 7.2±1.2% (P<.001) in the retrospective group. Hypoglycaemic and hyperglycaemic episodes and hospital readmissions were similar in both groups. CONCLUSIONS: Implementation of Spanish consensus recommendations for the management of hospital discharge in patients with diabetes type 2 or hyperglycaemia considerably improved the registration of quality indicators in the discharge report. Reconciliation of antidiabetic medication at the time of hospital discharge, improves glycaemic control after hospital discharge.

Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes--the HOSMIDIA study.

AIMS: Guidelines recommend use of basal-bolus insulin in hospitalised patients with hyperglycaemia, but information about implementation and medication reconciliation at discharge is scarce. The HOSMIDIA study evaluated a management program involving basal-bolus insulin and an algorithm for medication reconciliation at discharge in non-critically ill hospitalised patients with type 2 diabetes in clinical practice. METHODS: HOSMIDIA was a prospective, observational study performed during routine clinical practice at 15 Spanish hospitals during hospitalisation, with follow-up 3 months postdischarge. Study patients (n = 134) received a basal-bolus regimen with insulin glargine during hospitalisation and treatment at discharge was adjusted according to a simple algorithm. The control group (n = 62) included patients with similar characteristics hospitalised during the month before study initiation and had no follow-up after discharge. RESULTS: Compared with control subjects, patients in the prospective study achieved lower mean total (167.7 ± 41.1 vs. 190.5 ± 53.3 mg/dl) preprandial (164.2 ± 42.4 vs. 189.6 ± 52.6 mg/dl; p < 0.001) and fasting (137.0 ± 42.2 vs. 165.8 ± 56.5 mg/dl) blood glucose levels while hospitalised, without increased hypoglycaemic episodes (17.7% vs. 19.3% patients). In the prospective study, glycaemic control improved from admission to discharge, with control maintained 3 months after discharge. The main treatment modification at discharge compared with admission was addition of basal insulin, and treatment at discharge was maintained at 3 months in 89% of patients. CONCLUSION: The HOSMIDIA study confirmed that management of hyperglycaemia with basal-bolus insulin is feasible and effective in routine clinical practice, and that a simple strategy facilitating the reconciliation of medication on discharge can improve glycaemic control postdischarge.

The role of radiology coders and fee coordinators.

The coding process for radiology procedures is more than just looking at a report, writing in the codes and sending it on. In the radiology department, coders/fee coordinators play a key role in troubleshooting, since they are able to see the entire process from patient visit to billing. Vital to the billing operation is having competent and skilled coders who understand radiology from order to revenue. Responsibility for proper coding should rest with the radiology department, even when fee coordinators are paid from different sources. If other people are writing codes that can influence its bottom line, the department needs to know that coding is being done correctly. Thousands of dollars can be lost when the coding and billing process breaks down and incorrect coding is overlooked. A quality control program is vital so that mistakes are found and corrected prior to codes being entered. Insisting on accuracy also means finding and following up on errors through a troubleshooting system to prevent legal action. Codes must be able to look at reports, ask questions about inconsistencies and possible errors and compare the ordered procedure to what was actually done. Issues that affect proper coding are pointed out so that today's coders can be more watchful. Although it is labor intensive, it is important for coders to match reports with dictation from technologies and radiologists to ensure accuracy.